Low creatinine clearance, glucocorticoid treatment, rheumatoid arthritis - Different etiologies for low D-hormone syndrome and its associated increased risk for falls

Journal of Rheumatology

Volumn 32, Issue SUPPL. 76, 2005, Pages 44-46

  Dukas, Laurent C ^a   Schacht, Erich ^b  

^a Geriatrische Universitatsklinik   (Switzerland)

^b BALGRIST UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Alfacalcidol; Creatinine clearance; D hormone; Falls

Indexed keywords

ALFACALCIDOL; CHROMIUM CHLORIDE; COLECALCIFEROL DERIVATIVE; CYCLOSPORIN A; GLUCOCORTICOID; LOOP DIURETIC AGENT; 1-HYDROXYCHOLECALCIFEROL; BONE DENSITY CONSERVATION AGENT; CALCITRIOL; CREATININE; HYDROXYCOLECALCIFEROL; STEROID MONOOXYGENASE; VITAMIN; VITAMIN D 1 ALPHA HYDROXYLASE; VITAMIN D 1-ALPHA HYDROXYLASE;

CONFERENCE PAPER; CREATININE CLEARANCE; DRUG EFFECT; DRUG MECHANISM; DRUG SAFETY; FALLING; HUMAN; LOW D HORMONE SYNDROME; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; TREATMENT OUTCOME; VITAMIN D METABOLISM; VITAMIN DEFICIENCY; AGE; BLOOD; CLINICAL TRIAL; ENZYMOLOGY; KIDNEY; METABOLIC BONE DISEASE; METABOLISM; REVIEW; RISK FACTOR; SYNDROME;

ACCIDENTAL FALLS; AGE FACTORS; ARTHRITIS, RHEUMATOID; BONE DENSITY CONSERVATION AGENTS; BONE DISEASES, METABOLIC; CALCITRIOL; CLINICAL TRIALS; CREATININE; GLUCOCORTICOIDS; HUMANS; HYDROXYCHOLECALCIFEROLS; KIDNEY; RISK FACTORS; STEROID HYDROXYLASES; SYNDROME; VITAMINS;

EID: 24944477298     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (34)

1. Epstein S, Bryce G, Hinman JW, et al. The influence of age on bone mineral regulating hormones. Bone 1986;7:421-5.
2. Tsai KS, Heath H III, Kumar R, et al. Impaired vitamin D metabolism with aging in women: possible role in pathogenesis of senile osteoporosis. J Clin Invest 1984;73:1668-72.
3. Dukas L, Bischoff HA, Schacht E, et al. Normal 25(OH) vitamin D serum levels do not exclude D-hormone deficiency in community-dwelling elderly [abstract]. Osteoporos Int 2002;13:S35.
4. Slovik DM, Adams JS, Neer RM, et al. Deficient production of 1,25-dihydroxyvitamin D in elderly osteoporotic patients. N Engl J Med 1981;305:372-4.
5. Silverberg SH, Shane E, de la Cruz L, Segre GV, Clemens TL, Bilezikian JP. Abnormalities in parathyroid hormone secretion and 1,25-dihydroxyvitamin D3 formation in women with osteoporosis. New Engl J Med 1989;320:277-81.
6. Gallagher JC, Fowler SE, Detter JR, et al. Combination treatment with estrogen and calcitriol in the prevention of age-related bone loss. J Clin Endocrinol Metab 2001;3618-28.
7. Dukas L, Bischoff HA, Lindpaintner LS, et al. Alfacalcidol reduces the number of fallers in a community-dwelling elderly population with a minimum calcium intake of 500 mg daily. J Am Geriatr Soc 2004;52:230-6.
8. Ringe JD, Dorst A, Faber H, Schacht E, Rahlfs VW. Superiority of alfacalcidol over plain vitamin D in the treatment of glucocorticoid-induced osteoporosis [abstract]. Rheumatol Int 2004;24:63-70.
9. Dukas L, Schacht E, Staehelin HB. Use of diuretics is associated with lower D-hormone serum levels but not with serum 25-hydroxyvitamin D in community dwelling elderly men and women. Results from the baseline cross-sectional analyses of the Aims-Study. Osteoporos Int 2002;13:S75.
10. Ebert R, Jovanovic M, Ulmer M, et al. Downregulation by nuclear factor kappa B of human 25-hydroxyvitamin D3 1 alpha-hydroxylase promoter. Mol Endrocrinol 2004;18:2440-50.
11. Oelzner P, Müller A, Deschner F, et al. Relationship between disease activity and serum levels of vitamin D metabolites and PTH in rheumatoid arthritis. Calcif Tissue Int 1997;23:193-8.
12. Bonjour JP, Rizzoli R, Caverzasio J. Phosphate homeostasis, 1,25-dihydroxyvitamin-D3, and hyperparathyroidism in early chronic failure. Trends Endocrinol Metab 1992;3:301-5.
13. Reichel H, Deibert B, Schmidt-Gayk H, Ritz E. Calcium metabolism in early chronic renal failure: implications for the pathogenesis of hyperparathyroidism. Nephrol Dial Transplant 1991;6:162-9.
14. Trombetti A, Stoermann-Chopard C, Ferrari S, et al. Prevention of bone complications in patients with chronic kidney insufficiency [German]. Part I. Swiss Med Forum 2003;11:260-6.
15. Francis RM, Peacock M, Barkworth SA. Renal impairment and its effects on calcium metabolism in elderly women. Age Ageing 1984;13:14-20.
16. Dukas L, Schacht E, Mazor Z, Stähelin HB. A new significant and independent risk factor for falls in elderly men and women: A low creatinine clearance of less than 65 ml/min. Osteoporos Int 2005;16:332-8.
17. Nguyen TV, Eisman JA, Kelly PJ, Sambrook PN. Risk factors for osteoporotic fractures in elderly men. Am J Epidemiol 1986;144:255-63.
18. Chapuy MC, Preziosi P, Maamer M, et al. Prevalence of vitamin D insufficiency in an adult normal population. Osteoporos Int 1997;7:439-43.
19. Peacock M, Selby PL, Francis RM, Brown WB, Hordon L. Vitamin D deficiency, insufficiency, sufficiency and intoxication. What do they mean? In: Norman A, Schaefer K, Grigoletti MG, Herrath DV, editors. Sixth Workshop on vitamin D. Berlin and New York: de Gruyter; 1985:569-70.
20. Martinez I, Saracho R, Montenegro J, Liach F. The importance of dietary calcium and phosphorous in the secondary hyperparathyroidism of patients with early renal failure. Am J Kidney Dis 1997;29:496-502.
21. Peacock M, Heyburn P. Effect of vitamin D3 metabolites on proximal muscle weakness. Calcif Tiss Res 1977;24 Suppl:R20-3.
22. Schott GD, Wills MR. Muscle weakness in osteomalacia. Lancet 1976;20:626-9.
23. Bischoff HA, Stähelin HB, Urscheler N, et al. Muscle strength in the elderly: its relation to vitamin D metabolites. Arch Phys Med Rehabil 1999;80:54-8.
24. Dhesi JK, Bearne LM, Monitz C, et al. Neuromuscular and psychomotor function in elderly subjects who fall and the relationship with vitamin D status. J Bone Miner Res 2002;17:891-7.
25. Dukas L, Schacht E, Bischoff HA. Better functional mobility in community-dwelling elderly is related to D-hormone serum levels and to a daily calcium intake. J Nutr Health Aging 2005; published online.
26. Endo I, Inoue D, Mitwui T, et al. Deletion of vitamin D receptor gene in mice results in abnormal skeletal muscle development with deregulated expression of myoregulatory transcription factors. Endocrinology 2003;144:5138-44.
27. Bischoff-Ferrari HA, Borchers M, Gudat F, Dürmüller U, Stähelin HB, Dick W. Vitamin D receptor expression in human muscle tissue decreases with age. J Bone Miner Res 2004;19:265-9.
28. Godschalk M, Levy RJ, Downs RW. Glucocorticoids decrease vitamin D receptor numbers and gene expression in human osteosarcoma cells. J Bone Miner Res 1992;7:21-7.
29. Van Staa TP, Leufkens HGM, Abenhaim A, Zhang B, Cooper C. Use of oral corticosteroids and risk of fractures. J Bone Miner Res 2000;15:993-1000.
30. Poor G, Atkinson EJ, O'Fallon WM, et al. Predictors of hip fracture in elderly men. J Bone Miner Res 1995;10:1900-7.
31. Runge M, Schacht E. Multifactorial pathogenesis of falls as a basis for multifactorial interventions, J Musculoskelet Neuronal Interact 2005;5:127-34.
32. K/DOQI practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003;42 Suppl 3:S7-S28.
33. Klawansky S, Komaroff E, Cavanaugh PF, et al. The relationship between age, renal function and bone mineral density in the US population. Osteoporos Int 2003;14:570-6.
34. Dukas L, Schacht E, Mazor Z, Stähelin HB. Treatment with alfa-calcidol significantly decreases in elderly the high risk of falls associated with a low creatinine clearance of < 65 ml/min. Osteoporos Int 2005;16:198-203.